Navigation Links
Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
Date:2/5/2008

Company Ends Year with Cash and Investments of $81.4 Million

RICHMOND, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported 2007 fourth quarter and year-end financial results and accomplishments and provided an outlook for 2008.

For the fourth quarter ended December 31, 2007, Sangamo reported a consolidated net loss of $6.7 million, or $0.17 per share, compared to a net loss of $8.9 million, or $0.26 per share, for the same period in 2006. As of December 31, 2007, the company had cash, cash equivalents and investments of $81.4 million.

Revenues for the fourth quarter of 2007 were $2.8 million, compared to $2.2 million for the same period in 2006. Fourth quarter 2007 revenues were primarily from Sangamo's agreements with Dow AgroSciences (DAS), Sigma-Aldrich Corporation, research grants and enabling technology agreements in protein production.

Research and development expenses were $7.9 million for the 2007 quarter, compared to $10.1 million for the same period in 2006 which included the one-time costs of Sangamo's acquisition of Edwards Lifesciences' ZFP Therapeutic(TM) angiogenesis program, a transaction valued at $5.8 million of common stock. Excluding the one-time 2006 charge, the increase in research and development expenses for the fourth quarter of 2007 of $3.6 million was primarily due to advancing the Company's clinical development program in diabetic neuropathy and pre-IND programs to develop ZFP Therapeutics for the treatment of HIV/AIDS and glioblastoma, as well as increased R&D personnel costs and lab supply expenses. General and administrative expenses were $2.5 million for the fourth quarter of 2007, compared to $1.9 million for the same period in 20
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
4. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
5. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
6. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
7. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
8. Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles
9. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... -- The American Association for Homecare (AAHomecare), along with a ... announced today the filing of a lawsuit in ... asking that the scheduled July 1 expansion of the Medicare ... stopped because of serious licensing irregularities. The lawsuit ... Secretary Kathleen Sebelius as the defendant. HHS oversees ...
(Date:6/19/2013)... 19, 2013 Ellen MacArthur ... kommande tre åren kommer att vara en partner ... cirkulär ekonomi. Efter stiftelsens framgångsrika partnerskap ... Grid, kommer Philips att ansluta sig som partner ... i sin egen verksamhet och stödja stiftelsens arbete ...
(Date:6/19/2013)... , June 19, 2013  Finesse Solutions, Inc, ... life sciences process applications, announced the launch of ... upstream cell culture and fermentation.  The 3L glass ... family of Finesse bioreactors and are designed to ... They are fully compatible with all Finesse G3Lab ...
Breaking Medicine Technology:AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 2AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 3AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 4AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 5Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 2Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 3Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2
... 11, 2011 MedQuist Holdings Inc. (Nasdaq: ... of integrated clinical documentation solutions for the U.S. healthcare ... public offering of shares of its common stock.  The ... NASDAQ Global Market under the ticker symbol MEDH. ...
... Feb. 11, 2011 Vitalitec International, ... of the ENCLOSE II Anastomosis Assist Device from Novare ... was developed by Thomas Fogarty, MD, and is designed ... Bypass Procedures. Vitalitec International, Inc. is a ...
Cached Medicine Technology:MedQuist Holdings Inc. Announces Closing of Its Initial U.S. Public Offering and Acquisition of Additional Shares of MedQuist Inc. 2MedQuist Holdings Inc. Announces Closing of Its Initial U.S. Public Offering and Acquisition of Additional Shares of MedQuist Inc. 3
(Date:6/19/2013)... Addison, Texas (PRWEB) June 19, 2013 ... , today announced its intent to purchase ... Worth, Florida, a leader in wheelchair accessible vehicle ... acquisition of Auto Mobility Sales, Inc compliments and ... of wheelchair accessible mobility dealers . The ...
(Date:6/19/2013)... June 19, 2013 PrettySkin4Less announces it ... skin serums by top skin care manufacturer EMINENCE ... concentrations of vitamins, minerals and active organic ingredients to ... so many other beauty products offer. For this reason ... up. , "I like products that do what ...
(Date:6/19/2013)... CCA , America's leader in ... to Vice President, Health Services, effective June 8, 2013. ... Services for CCA. He will replace the retiring ... privilege to lead CCA's dedicated team of health care ... society and our partners as we provide effective care ...
(Date:6/19/2013)... NY (PRWEB) June 19, 2013 ... Awards program is this Friday, June 21 at ... campaigns, ongoing programs and innovative people who’ve raised ... more information, visit http://www.minonline.com/ima . , Any ... individual magazine title is eligible to enter. Additionally, ...
(Date:6/19/2013)... June 19, 2013 Brain not working? ... MS, explains why such seemingly minor brain problems as ... are vital red flags. They indicate the brain may ... sclerosis (MS), Alzheimer’s, Parkinson’s, stroke, and other neurological diseases. ... June 2013 by Elephant Press is now available online ...
Breaking Medicine News(10 mins):Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2Health News:CCA Names Dr. John Baxter Vice President, Health Services 2Health News:Entry Deadline for min’s Integrated Marketing Awards Is This Friday, June 21 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3
... American Journal of Transplantation reveals that cigarette smoke ... would have been prevented by certain drug treatments. Led ... Health Science Center, researchers used mouse transplant models to investigate ... and its mechanism of action. Seven to eight mice ...
... has shown that removing polyps by colonoscopy not only prevents ... disease. Patients in the study were evaluated for up to ... results to date. The collaborative study, led by researchers at ... 23, 2012 issue of The New England Journal of ...
... WEDNESDAY, Feb. 22 (HealthDay News) --,Toddlers are more likely to ... quickly and overreact to their children,s behavior, according to a ... behavior of adopted children aged 9 months, 18 months and ... 10 states. Researchers also analyzed genetic data from the children ...
... found that insulin production may persist for decades after the ... appears to be preserved in some patients years after apparent ... March issue of Diabetes Care . ... in patients with advanced type 1 diabetes. However, data ...
... HealthDay Reporter , TUESDAY, Feb. 21 (HealthDay News) -- ... sensitivity, but a new analysis suggests that many people who ... Health experts have claimed that this special diet can ... a substance found in wheat, barley, rye and possibly oats. ...
... HealthDay Reporter , TUESDAY, Feb. 21 (HealthDay ... patients with blocked leg arteries, a new European study ... disease, often suffer from intermittent claudication, which is pain ... legs. Animal experiments had suggested that aspirin might block ...
Cached Medicine News:Health News:Colonoscopy prevents deaths from colon cancer 2Health News:Toddlers With Angry Parents May Have More Temper Tantrums 2Health News:Study finds some insulin production in long-term Type 1 diabetes 2Health News:Is Avoiding Gluten in Foods Always Necessary? 2Health News:Is Avoiding Gluten in Foods Always Necessary? 3Health News:Aspirin as Good as Plavix for Poor Leg Circulation: Study 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: